Shenyang Xingqi PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Shenyang Xingqi PharmaceuticalLtd has a total shareholder equity of CN¥1.7B and total debt of CN¥100.1M, which brings its debt-to-equity ratio to 5.8%. Its total assets and total liabilities are CN¥2.1B and CN¥386.8M respectively. Shenyang Xingqi PharmaceuticalLtd's EBIT is CN¥273.0M making its interest coverage ratio -46.8. It has cash and short-term investments of CN¥567.9M.
Key information
5.8%
Debt to equity ratio
CN¥100.09m
Debt
| Interest coverage ratio | -46.8x |
| Cash | CN¥567.85m |
| Equity | CN¥1.74b |
| Total liabilities | CN¥386.84m |
| Total assets | CN¥2.12b |
Recent financial health updates
Recent updates
With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case
Aug 19
What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash
Jul 24Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?
Jun 28Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00
May 21After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar
May 10We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease
May 07Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump
Mar 15Financial Position Analysis
Short Term Liabilities: 300573's short term assets (CN¥976.9M) exceed its short term liabilities (CN¥312.9M).
Long Term Liabilities: 300573's short term assets (CN¥976.9M) exceed its long term liabilities (CN¥74.0M).
Debt to Equity History and Analysis
Debt Level: 300573 has more cash than its total debt.
Reducing Debt: 300573's debt to equity ratio has reduced from 9% to 5.8% over the past 5 years.
Debt Coverage: 300573's debt is well covered by operating cash flow (342.4%).
Interest Coverage: 300573 earns more interest than it pays, so coverage of interest payments is not a concern.